TIMMONS AND COMPANY, INC. for TEVA PHARMACEUTICALS USA INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 515 - A bill to amend title 35, United States Code, to provide for patent reform. S. 610 - A bill to amend title 35, United States Code, to provide for patent reform. H.R. 1260 - To amend title 35, United States Code, to provide for patent reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J BATES | — |
| MICHELLE BRIGHT | — |
| ERIN GRAEFE DORTON | — |
| BRYCE L HARLOW | — |
| CHARLES JONES New | Legislative Asst - Office of Senator Tom Carper |
| GINGER LOPER | — |
| MARTIN PAONE | — |
| WILLIAM E TIMMONS | — |
Health Issues HCR
H.R. 1427 - To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes. S. 726 - A bill to amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes. H.R. 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes. S. 1213 - A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Patient-Centered Outcomes Research Trust Fund, and for other purposes. S. 1259 - A bill to protect all patients by prohibiting the use of data obtained from comparative effectiveness research to deny coverage of items or services under Federal health care programs and to ensure that comparative effectiveness research accounts for advancements in personalized medicine and differences in patient treatment response.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J BATES | — |
| MICHELLE BRIGHT | — |
| ERIN GRAEFE DORTON | — |
| BRYCE L HARLOW | — |
| CHARLES JONES New | Legislative Asst - Office of Senator Tom Carper |
| GINGER LOPER | — |
| MARTIN PAONE | — |
| WILLIAM E TIMMONS | — |
Labor Issues/Antitrust/Workplace LBR
H.R. 1706 - To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369 - A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J BATES | — |
| MICHELLE BRIGHT | — |
| ERIN GRAEFE DORTON | — |
| BRYCE L HARLOW | — |
| CHARLES JONES New | Legislative Asst. - Office of Senator Tom Carper |
| GINGER LOPER | — |
| MARTIN PAONE | — |
| WILLIAM E TIMMONS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.